USES SKYRIZI is a prescription medicine used to treat adults with: moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV …

DOSING & MONITORING GUIDE INDICATIONS1 Crohn’s Disease: SKYRIZI is indicated for the treatment of moderately to severely active Crohn’s disease in adults. Ulcerative Colitis: SKYRIZI is …

May 8, 2025 · What is the best medicine for ulcerative colitis? The treatment options for ulcerative colitis vary based on the disease’s severity and can be categorized into six main types: conventional …

Risankizumab-rzaa may be used for the treatment of moderately to severely active UC in patients who have medical inadvisability to, or mechanistic failure of, a TNFi, or pharmacokinetic failure of …

Nov 6, 2025 · Finding the right treatment for ulcerative colitis can take time. What works well for one person might not work for another, and many people try several options before finding relief. …

Jul 23, 2024 · As a treatment for ulcerative colitis, Skyrizi works by fighting the inflammation that can lead to symptoms of the disease.

Jun 18, 2024 · The most common side effects of SKYRIZI in people treated for Crohn's disease and ulcerative colitis include: upper respiratory infections, headache, joint pain, stomach (abdominal) …

Jun 2, 2025 · As gastroenterologists navigate the unmet needs of refractory ulcerative colitis, the FDA approval of risankizumab for ulcerative colitis marks a watershed moment, introducing the first IL-23 …

TREATMENT OPTION? Starting SKYRIZI or any ulcerative colitis (UC) treatment is a big decision, and there are many things to consider when weighing options with your doctor.

Jun 19, 2024 · The US Food and Drug Administration (FDA) has approved Skyrizi (risankizumab-rzaa; AbbVie) for the treatment of moderately to severely active ulcerative colitis in adults. This approval …